239 related articles for article (PubMed ID: 37295542)
21. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives.
Verity DH; Marr JE; Ohno S; Wallace GR; Stanford MR
Tissue Antigens; 1999 Sep; 54(3):213-20. PubMed ID: 10519357
[TBL] [Abstract][Full Text] [Related]
22. Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51.
Yasuoka H; Yamaguchi Y; Mizuki N; Nishida T; Kawakami Y; Kuwana M
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S59-63. PubMed ID: 19026117
[TBL] [Abstract][Full Text] [Related]
23. Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells.
Pay S; Simşek I; Erdem H; Dinç A
Rheumatol Int; 2007 Mar; 27(5):417-24. PubMed ID: 17171346
[TBL] [Abstract][Full Text] [Related]
24. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease.
Paul M; Klein T; Krause I; Molad Y; Narinsky R; Weinberger A
Tissue Antigens; 2001 Sep; 58(3):185-6. PubMed ID: 11703827
[TBL] [Abstract][Full Text] [Related]
25. The association of Behçet's syndrome with HLA-B51 as understood in 2021.
Takeno M
Curr Opin Rheumatol; 2022 Jan; 34(1):4-9. PubMed ID: 34690278
[TBL] [Abstract][Full Text] [Related]
26. A comprehensive overview on the genetics of Behçet's disease.
Mahmoudi M; Aslani S; Meguro A; Akhtari M; Fatahi Y; Mizuki N; Shahram F
Int Rev Immunol; 2022; 41(2):84-106. PubMed ID: 33258398
[TBL] [Abstract][Full Text] [Related]
27. Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet's disease.
Hirohata S; Oka H; Mizushima Y
Cell Immunol; 1992 Apr; 140(2):410-9. PubMed ID: 1544169
[TBL] [Abstract][Full Text] [Related]
28. Behçet's disease: An immunogenetic perspective.
Salmaninejad A; Zamani MR; Shabgah AG; Hosseini S; Mollaei F; Hosseini N; Sahebkar A
J Cell Physiol; 2019 Jun; 234(6):8055-8074. PubMed ID: 30341905
[TBL] [Abstract][Full Text] [Related]
29. A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers.
Takeuchi M; Ombrello MJ; Kirino Y; Erer B; Tugal-Tutkun I; Seyahi E; Özyazgan Y; Watts NR; Gül A; Kastner DL; Remmers EF
Ann Rheum Dis; 2016 Dec; 75(12):2208-2211. PubMed ID: 27217550
[TBL] [Abstract][Full Text] [Related]
30. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome.
Arber N; Klein T; Meiner Z; Pras E; Weinberger A
Ann Rheum Dis; 1991 Jun; 50(6):351-3. PubMed ID: 2059078
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome analysis of immune cells from Behçet's syndrome patients: the importance of IL-17-producing cells and antigen-presenting cells in the pathogenesis of Behçet's syndrome.
Okubo M; Sumitomo S; Tsuchida Y; Nagafuchi Y; Takeshima Y; Yanaoka H; Shirai H; Kobayashi S; Sugimori Y; Maeda J; Hatano H; Iwasaki Y; Shoda H; Okamura T; Yamamoto K; Ota M; Fujio K
Arthritis Res Ther; 2022 Aug; 24(1):186. PubMed ID: 35941595
[TBL] [Abstract][Full Text] [Related]
32. Immunogenetic studies of Behçet's disease.
Mizuki N; Ohno S
Rev Rhum Engl Ed; 1996; 63(7-8):520-7. PubMed ID: 8896070
[TBL] [Abstract][Full Text] [Related]
33. Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and -B*5108 with Behçet's disease in Greek patients.
Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Shiina T; Palimeris GD; Kaklamani E; Ito D; Ohno S; Inoko H
Tissue Antigens; 2002 Feb; 59(2):118-21. PubMed ID: 12028538
[TBL] [Abstract][Full Text] [Related]
34. Behcet's disease associated with HLA-B51 and DRw52 antigens in Italians.
Baricordi OR; Sensi A; Pivetti-Pezzi P; Perrone S; Balboni A; Catarinelli G; Filippi F; Melchiorri L; Moncada A; Mattiuz PL
Hum Immunol; 1986 Nov; 17(3):297-301. PubMed ID: 2432045
[TBL] [Abstract][Full Text] [Related]
35. The immunogenetics of Behçet's disease: A comprehensive review.
Takeuchi M; Kastner DL; Remmers EF
J Autoimmun; 2015 Nov; 64():137-48. PubMed ID: 26347074
[TBL] [Abstract][Full Text] [Related]
36. Behçet's syndrome.
Yazici H; Yurdakul S; Hamuryudan V
Curr Opin Rheumatol; 1999 Jan; 11(1):53-7. PubMed ID: 9894631
[TBL] [Abstract][Full Text] [Related]
37. Behçet's disease: the first Mongolian case in literature showing HLA B51, MICA gene type *5/*6.
Chung YL; Bang DS; Lee ES; Lee SN; Mok JW; Park KS
Yonsei Med J; 2003 Oct; 44(5):935-8. PubMed ID: 14584116
[TBL] [Abstract][Full Text] [Related]
38. Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease.
Park SH; Park KS; Seo YI; Min DJ; Kim WU; Kim TG; Cho CS; Mok JW; Park KS; Kim HY
J Korean Med Sci; 2002 Jun; 17(3):366-70. PubMed ID: 12068141
[TBL] [Abstract][Full Text] [Related]
39. [Research for basic and clinical aspects of Behcet's disease--recent advance and future--].
Sakane T; Miura K
Nihon Rinsho; 1996 Mar; 54(3):870-84. PubMed ID: 8904250
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of Behçet's disease: autoinflammatory features and beyond.
Gül A
Semin Immunopathol; 2015 Jul; 37(4):413-8. PubMed ID: 26068404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
